Pharmacokinetics of guggulsterone after intravenous and oral administration in rats

Pharmacy and Pharmacology Communications

Volumn 5, Issue 5, 1999, Pages 349-354

  Verma, N ^a   Singh, S K ^a   Gupta, R C ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GUGGULSTERONE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; INTRAVENOUS DRUG ADMINISTRATION; ISOMERISM; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT;

EID: 0033057636     PISSN: 14608081     EISSN: None     Source Type: Journal    
DOI: 10.1211/146080899128734956     Document Type: Article

References (18)

1. Arya, V. P. (1988) Guggulipid. Drug Fut. 13: 618-619
2. Benn, W. R., Dodson, R. M. (1964) The synthesis and stereochemistry of isomeric 16-hydroxy-17(20)-pregnene. J. Org. Chem. 29: 1142-1147
3. Bressolle, F., Pistre, M. C., Bres, J., Sabatier, R. J. (1990) High-performance liquid chromatographic detection of 4-amino-5-chloro-N-[(1-ethylimidazolin-2-yl)methyl]-2 methoxybenzamide and its metabolite in biological fluids. Application in pharmacokinetic studies. J. Pharm. Sci. 79: 534-539
4. Gibaldi, M., Perrier, D. (1982) Pharmacokinetics. Marcel Dekker, Inc., New York
5. Jain, A. P. (1981) Clinical assessment of the value of oleoresin of Commiphora mukul in obesity and hyperlipidemia. ICR Bull 10: 83
6. Kapoor, N.-K., Nityanand, S. (1980) Guggulsterone in isoproterenol induced myocardial necrosis. Ind. J. Heart Res. 1: 22
7. Kappurajan, K., Rajgopalan, S. S., Kateswara, R., Sriraman, R. (1978) Effect of guggulu on serum lipid in obese, hypercholesterolaemic and hyperlipidaemic cases. J. Assoc. Phys. Ind. 26: 367
8. Kelmen, A. W. (1987) STATIS2 Statistical Package (Ver. 2. 1). Stobhffi General Hospital, Glasgow
9. Kinowski, J. M., Bressolle, F., Fabre, D., Goncalves, F., Panis, R. R., Galtier, M. (1994) High performance liquid chromatographic determination of ceftibuten and its metabolite in biological fluids: applications in pharmacokinetic studies. J. Pharm. Sci. 83: 736-741
10. Lauble, H., Kennedy, M. C., Beinert, H., Stout, C. D. (1994) Crystal structures of aconitase with trans-aconitate and nitrocitrate bound. J. Mol. Biol. 237: 437-451
11. Nityanand, S., Kapoor, N. K. (1975) Effects of sardine oil on atheromatous lesions in rats and rabbits. Ind. J. Pharmacol. 7: 43-46
12. Nityanand, S., Asthana, O. P., Gupta, P. P., Kapoor, N. K., Dhawan, B. N. (1981) Clinical studies with guggulipid, a new hypolipidaemic agent. Ind. J. Pharmacol. 13: 59-60
13. Patil, V. D., Nayak, V. R., Deo, S. (1972) Chemistry of ayurvedic crude drugs-1 guggulu (resin form) Commiphora mukul. Tetrahedron 28: 2341-2352
14. Shah, V. P., Midha, K. K., Dighe, S., McGilveray, U., Shelly, J. P., Yacobi, A., Laylol, T., Viswanathan, C. T., Cook, C. E., McDowall, R. D., Pittman, K. A., Spector, S. J. (1992) Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. J. Pharm. Sci. 81: 309-312
15. Singh, S. K., Verma, N., Gupta, R. C. (1995) Sensitive high-performance liquid chromatographic assay method for the determination of guggulsterone in serum. J. Chromatogr. Biomed. Appl. 670: 173-176
16. Tsai, T. H., Chen, C. F. (1992) Ultraviolet spectral identification of ferulic acid in rabbit plasma by HPLC and its pharmacokinetic application. Int. J. Pharm. 80: 75-79
17. Tsai, T. H., Chou, C. J., Chen, C. H. (1994) Pharmacokinetics of paenolol after intravenous administration in rats. J. Pharm. Sci. 83: 1307-1309
18. Verma, N., Singh, S. K., Gupta, R. C. (1998) Simultaneous determination of the stereoisomers of guggulsterone in serum by HPLC. J. Chromatogr. Biomed. Appl. 708: 243-248